[Ecns]Vaccine to undergo 3rd phase of trials
Special: Battle Against Novel Coronavirus China began its first Phase 3 clinical trials of a recombinant subunit vaccine against COVID-19 on Wednesday, making it the fifth Chinese vaccine candidate to enter late-stage human testing. The recombinant subunit vaccine is being jointly developed by Anhui Zhifei Longcom Biologic Pharmacy and ...